January 4, 2022 - The Biden administration has officially pulled a controversial model that would have tied prices for drugs reimbursed under Part B to prices paid by countries overseas. CMS issued a final rule last week that pulls the demonstration approved at the tail end of the Trump administration. Providers had slammed the model due to concerns over reimbursement. READ MORE